Cargando…

Caring for patients with advanced COPD: beyond the inhalers…

COPD affects millions of people worldwide. Patients with advanced COPD have a high symptom burden. Breathlessness, cough and fatigue are frequent daily symptoms. Guidelines often focus on pharmacological treatment, especially inhaler therapy, but other approaches in combination with medications offe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Michelle A., Mulryan, Kathryn, Ní Chléirigh, Maedhbh, Redmond, Karen C., Kelly, Emer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292785/ https://www.ncbi.nlm.nih.gov/pubmed/37378065 http://dx.doi.org/10.1183/20734735.0229-2022

Ejemplares similares

Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home
por: Ari, Arzu, et al.
Publicado: (2021)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

Improving adherence with inhaler therapy in COPD
por: Lareau, Suzanne C, et al.
Publicado: (2010)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
por: Neder, José Alberto, et al.
Publicado: (2019)

An evaluation of information online on artificial intelligence in medical imaging
por: Mulryan, Philip, et al.
Publicado: (2022)

Safety and tolerability of inhalational anticholinergics in COPD
por: Sharafkhaneh, Amir, et al.
Publicado: (2013)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Use of Respimat(®) Soft Mist™ Inhaler in COPD patients
por: Anderson, Paula
Publicado: (2006)

Choosing the right inhaler for your asthma or COPD patient
por: Usmani, Omar S
Publicado: (2019)

Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD
por: Donohue, James F, et al.
Publicado: (2023)

“Exposing force”: the COVID-19 pandemic and women's sport in Ireland during 2020–2021
por: Crosson, Seán, et al.
Publicado: (2023)

Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic?
por: Ni Chleirigh, Romy, et al.
Publicado: (2021)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
por: Jardim, Jose R., et al.
Publicado: (2019)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
por: Hilleman, Daniel E, et al.
Publicado: (2009)

Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
por: Ariel, Amnon, et al.
Publicado: (2017)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
por: Miravitlles, Marc, et al.
Publicado: (2022)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
por: Bourbeau, Jean, et al.
Publicado: (2021)

Evaluating inhaler use technique in COPD patients
por: Pothirat, Chaicharn, et al.
Publicado: (2015)

COPD: understanding patients’ adherence to inhaled medications
por: Duarte-de-Araújo, António, et al.
Publicado: (2018)

Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol
por: Albertson, Timothy E, et al.
Publicado: (2015)

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD
por: Albertson, Timothy E, et al.
Publicado: (2019)

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
por: D’Urzo, Anthony, et al.
Publicado: (2019)

Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports
por: Terry, Paul D., et al.
Publicado: (2020)

Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD
por: Mitzel, Holly, et al.
Publicado: (2022)

Single Inhaler LABA/LAMA for COPD
por: Malerba, Mario, et al.
Publicado: (2019)

Inhaled therapy reduces COPD mortality
por: Andreas, Stefan, et al.
Publicado: (2020)

The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
por: Terry, Paul D., et al.
Publicado: (2023)

Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
por: Zhang, Shiyuan, et al.
Publicado: (2020)

Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2012)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)

Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
por: Tantucci, Claudio, et al.
Publicado: (2020)

Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
por: Turégano-Yedro, Miguel, et al.
Publicado: (2023)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
por: Peng, Yating, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o3v21cck2o5k4vrqjhp2q6p26s